{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:21:56Z","timestamp":1781911316500,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ctro.2021.02.009","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T21:47:37Z","timestamp":1614289657000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis"],"prefix":"10.1016","volume":"28","author":[{"given":"Giuditta","family":"Chiloiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Meldolesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Giraffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola Dino","family":"Capocchiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunella","family":"Barbaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Coco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Corvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"De Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"D'Ugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2021.02.009_b0005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/DCR.0000000000000043","article-title":"Time for a renewed strategy in the management of rectal cancer: critical reflection on the surgical management of rectal cancer over 100 years","volume":"57","author":"Eh","year":"2014","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.ctro.2021.02.009_b0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2021.02.009_b0015","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdy161","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Glynne-Jones","year":"2018","journal-title":"Ann Oncol"},{"issue":"31","key":"10.1016\/j.ctro.2021.02.009_b0020","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04","volume":"30","author":"Ngan","year":"2012","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2021.02.009_b0025","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/annonc\/mdw062","article-title":"Long-course oxaliplatin-based preoperative chemoradiation versus 5 \u00d7 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study","volume":"27","author":"Bujko","year":"2016","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.ctro.2021.02.009_b0030","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2021.02.009_b0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijrobp.2007.12.019","article-title":"Prognostic Value of Pathologic Complete Response After Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Long-Term Analysis of 566 ypCR Patients","volume":"72","author":"Capirci","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2021.02.009_b0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.radonc.2020.09.026","article-title":"Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials","volume":"154","author":"Gambacorta","year":"2021","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2021.02.009_b0045","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1245\/s10434-007-9732-x","article-title":"Neoadjuvant chemoradiation and local excision for T2\u20133 rectal cancer","volume":"15","author":"Borschitz","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2021.02.009_b0050","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00384-015-2460-y","article-title":"1, Jao S-W C-WH 3. Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or \u201cwatch and wait\u201d","volume":"31","author":"Lai","year":"2016","journal-title":"Int J Color Dis"},{"issue":"7","key":"10.1016\/j.ctro.2021.02.009_b0055","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejso.2005.05.004","article-title":"Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer","volume":"31","author":"Guren","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctro.2021.02.009_b0060","doi-asserted-by":"crossref","unstructured":"Fleming FJ, Monson JRT The contemporary (over)treatment of rectal cancer: the goldilocks effect. Dis Colon Rectum 2014; 57:403\u20136. https:\/\/doi.org\/10.1097\/DCR.0000000000000042.","DOI":"10.1097\/DCR.0000000000000042"},{"issue":"16","key":"10.1016\/j.ctro.2021.02.009_b0065","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1200\/JCO.2014.60.1054","article-title":"Advances and challenges in treatment of locally advanced rectal cancer","volume":"33","author":"Smith","year":"2015","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ctro.2021.02.009_b0070","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.ejso.2015.09.008","article-title":"A new paradigm for rectal cancer: Organ preservation Introducing the International Watch & Wait Database (IWWD)","volume":"41","author":"Beets","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctro.2021.02.009_b0075","doi-asserted-by":"crossref","unstructured":"Habr-Gama A, Perez RO, NadalinW, sabbagaJ, Ribeiro JrU, Silva AH et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long- term results. Ann Surg 2004;240:711\u20137. https:\/\/doi.org\/10.1097\/01.sla.0000141194.27992.32.","DOI":"10.1097\/01.sla.0000141194.27992.32"},{"issue":"4","key":"10.1016\/j.ctro.2021.02.009_b0080","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ijrobp.2013.12.012","article-title":"Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control","volume":"88","author":"Habr-Gama","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.ctro.2021.02.009_b0085","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/bjs.8702","article-title":"Winter DC Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer","volume":"99","author":"Martin","year":"2012","journal-title":"Br J Surg"},{"issue":"35","key":"10.1016\/j.ctro.2021.02.009_b0090","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1200\/JCO.2011.37.7176","article-title":"Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer","volume":"29","author":"Maas","year":"2011","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ctro.2021.02.009_b0095","doi-asserted-by":"crossref","unstructured":"Dalton RSJ, Velineni R, Osborne ME,Thomas R, Harries S, Gee A S,IRD. A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management? Color Dis 2012; 14:567\u201371. https:\/\/doi.org\/10.1111\/j.1463-1318.2011.02752.x.","DOI":"10.1111\/j.1463-1318.2011.02752.x"},{"issue":"3","key":"10.1016\/j.ctro.2021.02.009_b0100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3109\/02841860903483692","article-title":"Could a wait and see policy be justified in T3\/4 rectal cancers after chemo-radiotherapy?","volume":"49","author":"Hughes","year":"2010","journal-title":"Acta Oncol (Madr)"},{"issue":"11","key":"10.1016\/j.ctro.2021.02.009_b0105","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/codi.15177","article-title":"Long-term outcomes of real world \u201cwatch and wait\u201d data for rectal cancer after neoadjuvant chemoradiotherapy","volume":"22","author":"Simpson","year":"2020","journal-title":"Color Dis"},{"key":"10.1016\/j.ctro.2021.02.009_b0110","doi-asserted-by":"crossref","unstructured":"van der Valk MJM, E Hilling D, Bastiaannet E, Kranenbarg E M-K, Beets GL, Figueiredo NL, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet (London, England) 2018;391:2537\u201345. https:\/\/doi.org\/10.1016\/S0140-6736(18)31078-X.","DOI":"10.1016\/S0140-6736(18)31078-X"},{"issue":"4","key":"10.1016\/j.ctro.2021.02.009_b0115","first-page":"e185896","article-title":"Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy. JAMA","volume":"5","author":"Smith","year":"2019","journal-title":"Oncol"},{"key":"10.1016\/j.ctro.2021.02.009_b0120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.radonc.2018.11.023","article-title":"The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)\u2013cT3 rectal cancer","volume":"134","author":"Valentini","year":"2019","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2021.02.009_b0125","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-017-0870-4","article-title":"Preoperative intensity-modulated radiotherapy with a simultaneous integrated boost combined with Capecitabine in locally advanced rectal cancer: Short-term results of a multicentric study","volume":"12","author":"Lupattelli","year":"2017","journal-title":"Radiat Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2021.02.009_b0130","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S1470-2045(15)00159-X","article-title":"Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO\/ARO\/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial","volume":"16","author":"R\u00f6del","year":"2015","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2021.02.009_b0135","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2015.04.003","article-title":"Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12\/PRODIGE 2 randomized trial","volume":"115","author":"G\u00e9rard","year":"2015","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.ctro.2021.02.009_b0140","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1245\/s10434-015-4687-9","article-title":"Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment","volume":"22","author":"Maas","year":"2015","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"10.1016\/j.ctro.2021.02.009_b0145","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00330-017-5026-2","article-title":"Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting","volume":"28","author":"Beets-Tan","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ctro.2021.02.009_b0150","first-page":"8","article-title":"Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: A population study on 2094 patients","volume":"4","author":"Macchia","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2021.02.009_b0155","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/codi.14994","article-title":"Postoperative chemotherapy improves survival in patients with resected high-risk Stage II colorectal cancer: results of a systematic review and meta-analysis","volume":"22","author":"Simillis","year":"2020","journal-title":"Color Dis"},{"issue":"5","key":"10.1016\/j.ctro.2021.02.009_b0160","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4321\/S1130-01082013000500003","article-title":"Quality of life assessment by applying EORTC questionnaires to rectal cancer patients after surgery and neoadjuvant and adjuvant treatment","volume":"105","author":"Arraras","year":"2013","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.ctro.2021.02.009_b0165","article-title":"Better quality of life and reduced fecal incontinence in rectal cancer patients with the watch-and-wait follow-up strategy","author":"Pascual-Russo","year":"2020","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.ctro.2021.02.009_b0170","doi-asserted-by":"crossref","unstructured":"Smith JD, Ruby JA, Goodman KA, Saltz LB,Guillem JG,Weiser MR, et al. Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. Ann Surg 2012;256:965\u201372. Doi: 10.1097\/SLA.0b013e3182759f1c.","DOI":"10.1097\/SLA.0b013e3182759f1c"},{"issue":"5","key":"10.1016\/j.ctro.2021.02.009_b0175","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S2468-1253(19)30410-8","article-title":"Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial","volume":"5","author":"Rullier","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.ctro.2021.02.009_b0180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S2468-1253(20)30333-2","article-title":"Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study","volume":"6","author":"Bach","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.ctro.2021.02.009_b0185","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2468-1253(17)30074-2","article-title":"A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis","volume":"2","author":"Dossa","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.ctro.2021.02.009_b0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1470-2045(15)00467-2","article-title":"Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis","volume":"17","author":"Renehan","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2021.02.009_b0195","doi-asserted-by":"crossref","unstructured":"Dattani M, Heald RJ, Goussous G, Broadhurst J, S\u00e3o Juli\u00e3o GP, Habr-Gama A, Perez RO. Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis. Ann Surg 2018;268:955\u201367. Doi: 10.1097\/SLA.0000000000002761","DOI":"10.1097\/SLA.0000000000002761"},{"key":"10.1016\/j.ctro.2021.02.009_b0200","doi-asserted-by":"crossref","unstructured":"B J P Hupkens1,MH Martens,JH Stoot,M Berbee,J Melenhorst,R G Beets-Tan et al Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection A Matched - Controlled Study Dis Colon Rectum 2017; 60(10): 1032-1040 doi: 10.1097\/DCR.0000000000000862.","DOI":"10.1097\/DCR.0000000000000862"},{"key":"10.1016\/j.ctro.2021.02.009_b0205","doi-asserted-by":"crossref","unstructured":"BB Vailati,A Habr-Gama,AE Mattacheo,GP Juli\u00e3o,RO Perez Quality of Life in Patients With Rectal Cancer After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection-Are We Comparing Apples to Oranges? Dis Colon Rectum 2018 Mar;61(3):e21. doi: 10.1097\/DCR.0000000000001018.","DOI":"10.1097\/DCR.0000000000001018"},{"key":"10.1016\/j.ctro.2021.02.009_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijsu.2018.02.003","article-title":"Long-term functional and oncological results after sphincter-saving resection for rectal cancer - Cohort study","volume":"52","author":"Badic","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.ctro.2021.02.009_b0215","doi-asserted-by":"crossref","unstructured":"Smith F Mc, Rao C, Perez RO, Bujko K, Athanasiou T, Habr-Gama A. Avoiding radical surgery improves early survival in elderly patients with rectal cancer, demonstrating complete clinical response after neoadjuvant therapy: results of a decision-analytic model. Dis Colon Rectum 2015;58:159\u201371. https:\/\/doi.org\/10.1097\/DCR.0000000000000281.","DOI":"10.1097\/DCR.0000000000000281"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630821000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630821000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:08:44Z","timestamp":1762502924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630821000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":43,"alternative-id":["S2405630821000227"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2021.02.009","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2021.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}